Stephen R. Hazelrigg
Papers
1
Total Citations
15
H-Index
1
About
Dr. Stephen R. Hazelrigg is a leading thoracic surgeon whose research has significantly advanced the field of minimally invasive thoracic surgery and perioperative pain management. His work focuses on optimizing patient outcomes through innovative surgical techniques and enhanced recovery protocols. Dr. Hazelrigg's most cited study, a randomized trial comparing bupivacaine versus liposomal bupivacaine in minimally invasive lobectomy (2022, 15 citations), directly addresses a critical clinical question: how to best manage post-surgical pain while reducing opioid reliance. This work has practical implications for improving patient comfort and accelerating recovery after lung cancer surgery. Beyond this landmark trial, his broader contributions include pioneering approaches to video-assisted thoracoscopic surgery (VATS) and refining pain control strategies that have become standard in thoracic surgical practice. Dr. Hazelrigg's research is characterized by its direct translational impact—bridging the gap between clinical evidence and bedside care. His dedication to rigorous, patient-centered investigation has made him a respected voice in thoracic surgery, influencing both surgical technique and postoperative management protocols in major medical centers.
Research Focus
Key Achievements
Top Papers
- 1